The findings of the association of serum cystatin C with cognitive impairment were inconsistent: one study did not find any associations in AD patients (Zhong et al., 2013), but another study found a significant correlation between serum cystatin C levels and MMSE scores in female AD patients (Wang R. et al., 2017). This evidence concerns the gene CST3 and Alzheimer disease.